Particle.news
Business ❯ Corporate Governance
Fraud Financial Reporting False Statements Securities Fraud Fraudulent Activities Investor Relations Bribery Short Selling Fiduciary Duty Investor Rights Executive Accountability Financial Fraud Fraudulent Practices Accounting Practices Mining Industry Post Office Management Investigations Investment Practices Financial Mismanagement Financial Crimes Executive Misconduct False Advertising Management Issues Fraudulent Schemes Disclosure Obligations Fraud Allegations Legal Actions Financial Diversion Islamic Firms Employee Relations Leadership Scandals Sexual Misconduct Data Privacy Management Accountability Legal Proceedings Antitrust Issues Legal Disputes Global Depository Receipts Failure to Disclose
The pending Northern District of California case challenges disclosures about Cytokinetics’ aficamten review after an FDA‑requested REMS delayed the timeline.